HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA
Clinical trials for HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA explained in plain language.
Never miss a new study
Get alerted when new HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA trials appear
Sign up with your email to follow new studies for HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Meal timing may matter for new sickle cell drug
Knowledge-focused CompletedThis study looked at how a high-fat meal changes the amount of the drug etavopivat in the blood of 16 healthy adults. Participants took a single dose of etavopivat after eating a high-fat meal and on an empty stomach on separate days. The goal is to understand if food affects how…
Matched conditions: HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New drug interaction study aims to keep sickle cell patients safe
Knowledge-focused CompletedThis completed Phase 1 study in 37 healthy adults tested whether a new drug called etavopivat affects how the body processes five common medicines: digoxin, rosuvastatin, midazolam, pitavastatin, and metformin. Participants took etavopivat daily for 10 days along with single dose…
Matched conditions: HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC